Sponsor
Seth Magaziner
Representative · D-RI
Representative · D-RI
The bill makes it easier for sellers to market Stenotomus chrysops as "Golden Sea Bream," improving availability and lowering compliance costs, at the cost of increased risk of misleading labeling and a narrowed FDA enforcement precedent that could weaken future seafood labeling oversight.
Consumers will more easily find and purchase Stenotomus chrysops because it can be sold under the standardized common name "Golden Sea Bream," improving product availability and clarity in the market.
Small seafood sellers and retailers can label and sell Stenotomus chrysops as "Golden Sea Bream" with reduced risk of FDA enforcement for that name, lowering regulatory uncertainty and compliance costs for those businesses.
Consumers may be misled if the name "Golden Sea Bream" is applied broadly to other species, increasing the risk that buyers receive a different fish than they expect.
Consumers and regulators could face reduced protection against seafood naming fraud because this limit on FDA enforcement in this case may set a precedent that constrains future oversight of seafood labeling.
Based on analysis of 2 sections of legislative text.
Authorizes use of the market name "Golden Sea Bream" for Stenotomus chrysops and prevents FDA enforcement based solely on that name.
Authorizes use of the market name "Golden Sea Bream" for the species Stenotomus chrysops and prevents the Food and Drug Administration from treating a food as misbranded, adulterated, or otherwise in violation of the Federal Food, Drug, and Cosmetic Act solely because it is labeled or marketed with that name. In short, sellers may use "Golden Sea Bream" on labels and in marketing without facing FDA enforcement actions based only on that name.
Official title: To establish "Golden Sea Bream" as an acceptable market name for Stenotomus chrysops.
Introduced March 4, 2025 by Seth Magaziner · Last progress March 4, 2025